Do you suffer from symptomatic non-erosive gastroesophageal reflux disease? A clinical trial might be an option for you!

The purpose of this study, which involves research, is to determine whether the investigational drug, vonoprazan, is safe and effective in the potential treatment of symptomatic non-erosive gastroesophageal reflux disease compared to a placebo.

You might qualify to participate if you have been experiencing frequent heartburn over the last six months. You must be at least 18 years old and will need to meet with a physician who is participating in this study to determine if you are fully eligible and if this study is right for you.